Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease
Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced that the Company has received a EUR 2.…
Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced that the Company has received a EUR 2.…
Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced the publication of two studies further…
Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, and Virome…
The second-generation COP Allergy Vaccines met the preset success criteria: strong TH1 response, absence of IgE response…
Rabobank, the Dutch multi-national bank and financial services company, is working with IBM to use cryptographic pseudon…
Agilent Technologies Inc. (NYSE: A) today announced the latest release of GoldenGate, its RFIC simulation, verification…
. - Treatment with AllerT increases allergen-specific IgG4 antibody levels by a factor of 20 - AllerT administration…
. - AllerT 50 μg meets primary and secondary endpoints - Vaccine improves quality of life and symptom scores Aner…
Anergis SA is a clinical-stage biopharmaceutical company developing innovative immunotherapies against allergies. Its le…
A series of research studies have demonstrated the benefit of the xCELLigence System for functional screening of G-prote…